Corvus Pharmaceuticals Investor Relations Material
Latest events
Q1 2024
Corvus Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Corvus Pharmaceuticals Inc
Access all reports
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies for the treatment of cancers. It develops COR 09012, a patient-specific CAR T cell therapy for the potential treatment of hematologic malignancies and solid tumors. The company was incorporated in 2014 and is based in Burlingame, California.
Key slides for Corvus Pharmaceuticals Inc
Corporate Presentation
Corvus Pharmaceuticals Inc
Corporate Presentation
Corvus Pharmaceuticals Inc
Latest articles
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
CRVS
Country
🇺🇸 United States